This website isn’t supported by Internet Explorer.
We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
When it comes to treating type 2 diabetes, there are more options available than ever before. Find out more about the benefits of an early SHIFT in treatment and glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
The first and only oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) for the treatment of type 2 diabetes.
Discover the potential with semaglutide for the treatment of type 2 diabetes.
For healthcare professionals only